Search results
Results from the WOW.Com Content Network
Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment . The company was founded in 1998 and went public in 2004.
Halozyme Therapeutics has had an incredible year, rallying more than 100% since the beginning of 2013. However, the ride up has been a very bumpy one, due to two major developments involving its ...
What: Shares of Halozyme Therapeutics (NAS: HALO) Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they ...
Small-caps and large-caps are wildly popular among investors, however, mid-cap stocks, such as Halozyme Therapeutics Inc (NASDAQ:HALO), with a market capitalization of US$2.2b, rarely draw their ...
For premium support please call: 800-290-4726 more ways to reach us
We think all investors should try to buy and hold high quality multi-year winners. While the best companies are hard to...
Halozyme Therapeutics, Inc. (NASDAQ:HALO) saw its shares rise on Friday after the company announced it was withdrawing its proposal to acquire Evotec SE (NASDAQ:EVO) for 11 euro ($11.44) per share ...
For premium support please call: 800-290-4726 more ways to reach us